Organon & Co. is a global health care company. Co. is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and established brands. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Co.'s Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, respiratory, dermatology and non-opioid pain management.
When researching a stock like Organon, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from OGN Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for OGN stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the OGN 200 day moving average ("OGN 200 DMA"), while one of the most popular "shorter look-backs" is the OGN 50 day moving average ("OGN 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Organon. Comparing two moving averages against each other can be a useful visualization tool: by calculating the difference between the OGN 200 DMA and the OGN 50 DMA, we get a moving average convergence divergence indicator ("OGN MACD"). The OGN MACD chart, in conjunction with the chart of the moving averages, basically helps in visualizing how the moving averages are showing convergence (moving closer together), or divergence (moving farther apart). |
Free OGN Email Alerts:
Video: Technical Analysis